companies that make glp 1 drugs GLP-1 from the Gray Market How to Invest in GLP-1
Description
In Study 2 (participants using PAP therapy), the results were even better, with an average AHI reduction of 29.3 events per hour versus 5.5 for placebo
All GLP-1 receptor agonists carry a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and are contraindicated in patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2
However, Andersons research shows sales have doubled annually for GLP-1s as obesity drugs, reaching $11.77 billion in 2024, up from $4.11 billion in 2023
& Clise, C
